Source link : https://newshealth.biz/health-news/fda-approves-oral-antiviral-to-prevent-covid-19-after-exposure/
The FDA approved the oral antiviral agent ensitrelvir (Xocova) to help prevent COVID-19 in people ages 12 years or older who were exposed to the SARS-CoV-2 virus, drugmaker Shionogi announced. Ensitrelvir is a SARS-CoV-2 main protease inhibitor also approved in Japan as COVID-19 postexposure prophylaxis (PEP) and as a treatment for mild to moderate COVID. […]
The post FDA Approves Oral Antiviral to Prevent COVID-19 After Exposure first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-01 18:10:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8